常山药业：肝素钠注射液获土库曼斯坦药品注册证书

Core Viewpoint - The company has received a drug registration certificate for its Heparin Sodium Injection from the Turkmenistan drug regulatory authority, which is expected to positively impact its expansion into overseas markets [1] Group 1: Product Approval - The Heparin Sodium Injection is in an injectable form with a specification of 5ml and a validity period of 5 years [1] - This drug is used for the prevention and treatment of thrombosis and related diseases [1] Group 2: Market Impact - The approval is seen as a positive step for the company's overseas market expansion [1] - Currently, the overseas sales revenue from heparin preparations constitutes a low proportion of the company's total revenue [1] Group 3: Sales Influences - Drug sales are influenced by various factors including overseas policies, exchange rates, and competition [1]